NINE MONTHS RESULTS
Strides Pharma Science Ltd.
BSE
Jun 19, 04:01
840.65
-13.65 ( -1.60%)
Volume
31538
Prev. Close
854.30
Open Price
852.20
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:54
845.25
-8.55 ( -1.00%)
Volume
282487
Prev. Close
853.80
Open Price
854.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
845.25 (1188)
You can view the
Nine Months Results
for the last 5 years.
|
ISIN No
|
INE939A01011
|
Market Cap. ( ₹ in Cr. )
|
7790.05
|
P/BV
|
3.43
|
Book Value ( ₹ )
|
246.48
|
|
BSE Code
|
532531
|
52 Week High/Low ( ₹ )
|
1675/513
|
FV/ML
|
10/1
|
P/E(X)
|
2.17
|
|
NSE Code
|
STAREQ
|
Book Closure
|
09/09/2024
|
EPS ( ₹ )
|
389.90
|
Div Yield (%)
|
0.47
|
(₹ in Crs.)
| Net Sales/Income from operations | 1583.47 | 1535.63 | 1290.94 | 1523.35 | 1223.97 |
| Total Income From Operations | 1583.47 | 1535.63 | 1290.94 | 1523.35 | 1223.97 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 779.82 | 806.18 | 816.55 | 692.04 | 669.08 |
| Purchase of Traded Goods | 51.98 | 18.24 | 19.34 | 32.74 | 48.12 |
| Increase/Decrease in Stocks | -30.50 | -29.46 | -25.72 | 110.86 | -49.26 |
| Employees Cost | 285.73 | 248.61 | 202.48 | 218.68 | 199.09 |
| Depreciation | 62.24 | 63.86 | 70.91 | 79.96 | 74.62 |
| Other Expenses | 301.94 | 327.58 | 299.24 | 410.23 | 257.64 |
| Total Expenses | 1451.19 | 1435.00 | 1382.81 | 1544.51 | 1199.29 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 132.27 | 100.62 | -91.87 | -21.16 | 24.68 |
| Other Income | 34.07 | 42.67 | 57.69 | 38.66 | 65.69 |
| P/L Before Interest, Excpt. Items & Tax | 166.34 | 143.30 | -34.18 | 17.50 | 90.37 |
| Interest | 116.55 | 121.16 | 95.78 | 52.69 | 47.43 |
| P/L Before Exceptional Items & Tax | 49.79 | 22.13 | -129.96 | -35.20 | 42.94 |
| Exceptional Items | -0.03 | -5.29 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | 49.76 | 16.84 | -129.96 | -35.20 | 42.94 |
| Tax | 6.73 | 5.02 | -72.25 | -14.88 | 12.78 |
| P/L After Tax from Ordinary Activities | 43.03 | 11.83 | -57.72 | -20.32 | 30.17 |
| Extra Ordinary Item | 2827.06 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit/Loss For the Period | 2870.08 | 11.83 | -57.72 | -20.32 | 30.17 |
| | | | | | |
| Equity Share Capital | 92.16 | 91.88 | 90.30 | 89.78 | 89.63 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 312.09 | 1.30 | -6.41 | -2.26 | 3.37 |
| Diluted EPS (Rs.) | 312.06 | 1.30 | -6.41 | -2.26 | 3.36 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 312.09 | 1.30 | -6.41 | -2.26 | 3.37 |
| Diluted EPS (Rs.) | 312.06 | 1.30 | -6.41 | -2.26 | 3.36 |
| | | | | | |
| PBITOE Margin (%) | 8.35 | 6.55 | -7.11 | -1.38 | 2.01 |
| PBTE Margin (%) | 3.14 | 1.44 | -10.06 | -2.31 | 3.50 |
| PBT Margin (%) | 3.14 | 1.09 | -10.06 | -2.31 | 3.50 |
| PAT Margin (%) | 181.25 | 0.77 | -4.47 | -1.33 | 2.46 |